Evidence map›Paper›PMID 35589713›Full record

ArticleNature communications2022

BMP4 drives primed to naïve transition through PGC-like state.

Shengyong Yu, Chunhua Zhou, Jiangping He, Zhaokai Yao, Xingnan Huang, Bowen Rong, Hong Zhu, Shijie Wang, Shuyan Chen, Xialian Wang and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. MECP2Science China. Life sciences · 2026
    Article
  2. Article
  3. Article
  4. ImprovingJournal of biomedical research · 2025
    Article
  5. BRD8 Guards the Pluripotent State by Sensing and Maintaining Histone Acetylation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 1 country.

Shengyong Yu *Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Chunhua Zhou *Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Jiangping He *Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.ORCID 0000-0002-1425-3530
Zhaokai YaoState Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.ORCID 0000-0001-8830-5527
Xingnan HuangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, 310024, China.
Bowen RongShanghai Key Laboratory of Medical Epigenetics, State International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Hong ZhuCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Shijie WangGMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
Shuyan ChenCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Xialian WangGMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
Baomei CaiCenter for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
Guoqing ZhaoCenter for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
Yuhan ChenState Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Lizhan XiaoCenter for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
He LiuCenter for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
Yue QinCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Jing GuoCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Haokaifeng WuCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Zhen ZhangCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Man ZhangCenter for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.ORCID 0000-0002-4704-4356
Xiaoyang ZhaoState Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.ORCID 0000-0003-2544-8293
Fei LanShanghai Key Laboratory of Medical Epigenetics, State International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yixuan WangCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Jiekai ChenCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.ORCID 0000-0001-5168-7074
Shangtao CaoCenter for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China. cao_shangtao@grmh-gdl.cn.ORCID 0000-0003-1379-0008
Duanqing PeiLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, 310024, China. peiduanqing@westlake.edu.cn.ORCID 0000-0002-5222-014X
Jing LiuCenter for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China. liu_jing@gibh.ac.cn.ORCID 0000-0003-1600-7744
Chinese Academy of Sciences · CNGuangzhou Regenerative Medicine and Health Guangdong Laboratory · CNSouthern Medical University · CNFudan University · CNGuangzhou Medical University · CNWestlake University · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple pluripotent states have been described in mouse and human stem cells. Here, we apply single-cell RNA-seq to a newly established BMP4 induced mouse primed to naïve transition (BiPNT) system and show that the reset is not a direct reversal of cell fate but goes through a primordial germ cell-like cells (PGCLCs) state. We first show that epiblast stem cells bifurcate into c-Kit

Indexed as

Germ CellsGerm LayersAnimalsBone Morphogenetic Protein 4Cell DifferentiationMaleMiceStem CellsTrophoblastsBmp4 protein, mouseBone Morphogenetic Protein 4

Identifiers

PMID35589713
PMCPMC9120449
OpenAlexW4280538574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.